AUS
NZ
UK
CA
USA
IND
Highlights
- Chimeric Therapeutics will be presenting at the Biotech Showcase 2024, which is due to held on 9 January 2024 in San Francisco.
- The conference offers an opportunity for life science entrepreneurs to come together and discover the potential of innovative technologies in drug discovery.
- The conference takes place every year in San Fransisco.
In the latest announcement, Chimeric Therapeutics (ASX:CHM) informed that it will be presenting at the Biotech Showcase 2024 being held in conjunction with JP Morgan Week. The event is schedule to take place on 9 January 2024 at Yosemite C, Hilton San Francisco.
Biotech Showcase is an investor conference produced by Demy-Colton and EBD Group. The focus of the conference is on driving advances in therapeutic development by offering a networking platform to the investors and executives that encourages partnership and investment opportunities. The conference happens every year in San Francisco.
The Chief Executive Officer of Demy-Colton Sara Demy highlighted that Biotech Showcase presents an opportunity to the life science investors and entrepreneurs to unite and discover the potential of groundbreaking technologies that will share the future of drug industry.
Here’s what CHM’s CEO commented on participation of CHM in the event:
CHM shares traded 3.70% up at AU$0.028 apiece at the time of writing on 21 December 2023 with a market cap of AU$19.46 million.
